BioVie Statistics

Total Valuation

BioVie has a market cap or net worth of $16.50 million. The enterprise value is -$7.52 million.

Market Cap	16.50M
Enterprise Value	-7.52M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BioVie has 18.45 million shares outstanding. The number of shares has increased by 123.13% in one year.

Current Share Class	18.45M
Shares Outstanding	18.45M
Shares Change (YoY)	+123.13%
Shares Change (QoQ)	+145.64%
Owned by Insiders (%)	0.50%
Owned by Institutions (%)	4.21%
Float	16.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.69
P/TBV Ratio	0.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.94, with a Debt / Equity ratio of 0.02.

Current Ratio	16.94
Quick Ratio	16.75
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.20

Financial Efficiency

Return on equity (ROE) is -154.54% and return on invested capital (ROIC) is -71.15%.

Return on Equity (ROE)	-154.54%
Return on Assets (ROA)	-63.41%
Return on Invested Capital (ROIC)	-71.15%
Return on Capital Employed (ROCE)	-98.76%
Revenue Per Employee	n/a
Profits Per Employee	-$1.82M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.82% in the last 52 weeks. The beta is 1.27, so BioVie's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-81.82%
50-Day Moving Average	1.12
200-Day Moving Average	2.24
Relative Strength Index (RSI)	47.25
Average Volume (20 Days)	202,699

Short Selling Information

The latest short interest is 1.41 million, so 7.67% of the outstanding shares have been sold short.

Short Interest	1.41M
Short Previous Month	1.25M
Short % of Shares Out	7.67%
Short % of Float	8.82%
Short Ratio (days to cover)	5.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.94M
Pretax Income	-36.29M
Net Income	-25.53M
EBITDA	-23.71M
EBIT	-23.94M
Earnings Per Share (EPS)	-$3.13

Full Income Statement

Balance Sheet

The company has $24.41 million in cash and $382,026 in debt, giving a net cash position of $24.02 million or $1.30 per share.

Cash & Cash Equivalents	24.41M
Total Debt	382,026
Net Cash	24.02M
Net Cash Per Share	$1.30
Equity (Book Value)	23.92M
Book Value Per Share	1.30
Working Capital	23.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.02M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-123.13%
Shareholder Yield	-123.13%
Earnings Yield	-154.73%
FCF Yield	n/a

Analyst Forecast

The average price target for BioVie is $30.00, which is 3,255.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	3,255.33%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 6, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 6, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2